Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment

  • Jeroen W.G. Derksen
  • , Graham W. Warren
  • , Karin Jordan
  • , Stefan Rauh
  • , Ruth Vera García
  • , Deirdre O'Mahony
  • , Samreen Ahmed
  • , Peter Vuylsteke
  • , Sinisa Radulovic
  • , Nikolaos Tsoukalas
  • , Piotr J. Wysocki
  • , Markus Borner
  • , Alvydas Cesas
  • , Anneli Elme
  • , Heikki Minn
  • , Gustav J. Ullenhag
  • , Jeanine M.L. Roodhart
  • , Miriam Koopman
  • , Anne M. May

Producción científica: Articlerevisión exhaustiva

12 Citas (Scopus)

Resumen

Background: Smoking cessation after a cancer diagnosis is associated with improved overall survival. Few studies have reported oncologists' cessation practice patterns, but differences between the curative and palliative settings have not been described. We aimed to study the oncologist's perceptions on patients' tobacco use, current practices and barriers to providing smoking cessation support, while distinguishing between treatment with curative (C) and palliative (P) intent. Methods: In 2019, an online 34-item survey was sent to approximately 6235 oncologists from 16 European countries. Responses were descriptively reported and compared by treatment setting. Results: Responses from 544 oncologists were included. Oncologists appeared to favour addressing tobacco in the curative setting more than in the palliative setting. Oncologists believe that continued smoking impacts treatment outcomes (C: 94%, P: 74%) and that cessation support should be standard cancer care (C: 95%, P: 63%). Most routinely assess tobacco use (C: 93%, P: 78%) and advise patients to stop using tobacco (C: 88%, P: 54%), but only 24% (P)–39% (C) routinely discuss medication options, and only 18% (P)–31% (C) provide cessation support. Hesitation to remove a pleasurable habit (C: 13%, P: 43%) and disbelieve on smoking affecting outcomes (C: 3%, P: 14%) were disparate barriers between the curative and palliative settings (p < 0.001), but dominant barriers of time, resources, education and patient resistance were similar between settings. Conclusion: Oncologists appear to favour addressing tobacco use more in the curative setting; however, they discuss medication options and/or provide cessation support in a minority of cases. All patients who report current smoking should have access to evidence-based smoking cessation support, also patients treated with palliative intent given their increasing survival.

Idioma originalEnglish
Páginas (desde-hasta)99-108
Número de páginas10
PublicaciónEuropean Journal of Cancer
Volumen138
DOI
EstadoPublished - oct 2020

Nota bibliográfica

Publisher Copyright:
© 2020 The Authors

Financiación

The present study is supported by an unrestricted grant from the Province of Utrecht , The Netherlands.

Financiadores
Province of Utrecht

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Huella

    Profundice en los temas de investigación de 'European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment'. En conjunto forman una huella única.

    Citar esto